Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

CF Industries Holdings, Inc. manufactures and sells hydrogen and nitrogen products for energy, fertilizer, emissions abatement, and other industrial activities worldwide. Its principal products include anhydrous ammonia, granular urea, urea ammonium nitrate, and ammonium nitrate products. The company also offers diesel exhaust fluid, urea liquor, nitric acid, and aqua ammonia products; and compound fertilizer products with nitrogen, phosphorus, and potassium. It primarily serves cooperatives, independent fertilizer distributors, traders, wholesalers, and industrial users. The company was founded in 1946 and is headquartered in Deerfield, Illinois.

CF Industries Holdings, Inc.

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's revenue

Revenue Growth

Assessment of recent increases in earnings per share, indicating profitability

EPS Growth

Review of the company's ability to generate free cash flow over recent periods

FCF Growth

Analysis of Return on Equity, showing how effectively the company uses equity to generate profits

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

MODESTE, LA.--(BUSINESS WIRE)--BLUE POINT ONE, A JOINT VENTURE BETWEEN CF INDUSTRIES HOLDINGS, INC. (NYSE: CF), THE WORLD'S LARGEST PRODUCER OF AMMONIA; JERA CO., INC. (JERA), JAPAN'S LARGEST ENERGY COMPANY; AND MITSUI & CO., LTD. (MITSUI), A LEADING GLOBAL INVESTMENT AND TRADING COMPANY, TODAY BROKE GROUND IN MODESTE, LOUISIANA, ON A LOW-CARBON AMMONIA PLANT THAT CAN SERVE BOTH TRADITIONAL AGRICULTURAL CUSTOMERS AND EMERGING ENERGY APPLICATIONS. THE PLANT IS EXPECTED TO BE THE WORLD'S LARG.

CF INDUSTRIES, JERA CO., AND MITSUI & CO., LTD., BREAK GROUND ON BLUE POINT ONE, THE WORLD'S LARGEST LOW-CARBON AMMONIA PLANT IN LOUISIANA

NORTHBROOK, ILL.--(BUSINESS WIRE)--CF INDUSTRIES HOLDINGS, INC. (NYSE: CF), A LEADING GLOBAL MANUFACTURER OF HYDROGEN AND NITROGEN PRODUCTS, TODAY ANNOUNCED RESULTS FOR THE FIRST HALF AND SECOND QUARTER ENDED JUNE 30, 2026. HIGHLIGHTS FIRST HALF 2026 NET EARNINGS(1) OF $1.34 BILLION, OR $8.71 PER DILUTED SHARE, EBITDA(2) OF $2.17 BILLION, AND ADJUSTED EBITDA(2) OF $2.18 BILLION. FIRST HALF 2026 FINANCIAL RESULTS INCLUDE A GAIN OF APPROXIMATELY $170 MILLION FROM A LITIGATION SETTLEMENT SECOND QU.

CF INDUSTRIES HOLDINGS, INC. REPORTS FIRST HALF 2026 NET EARNINGS OF $1.34 BILLION, ADJUSTED EBITDA OF $2.18 BILLION

NORTHBROOK, ILL.--(BUSINESS WIRE)--CF INDUSTRIES HOLDINGS, INC. (NYSE: CF) TODAY REPORTED THAT ITS BOARD OF DIRECTORS HAS DECLARED A $0.60 PER SHARE DIVIDEND ON ITS COMMON STOCK, A 20% INCREASE COMPARED TO ITS PRIOR QUARTERLY DIVIDEND. THE DIVIDEND WILL BE PAYABLE ON AUGUST 31, 2026, TO STOCKHOLDERS OF RECORD AS OF AUGUST 14, 2026. ADDITIONALLY, THE COMPANY CONFIRMED THAT IT WILL REPORT ITS SECOND QUARTER AND FIRST HALF 2026 RESULTS AFTER THE MARKET CLOSE ON WEDNESDAY, AUGUST 5, 2026. THE COMPA.

CF INDUSTRIES HOLDINGS, INC. ANNOUNCES 20% INCREASE IN QUARTERLY DIVIDEND

FIRST-IN-HUMAN PHASE 1 STUDY IN 56 HEALTHY PARTICIPANTS DEMONSTRATED KIT2014'S SAFETY AND TOLERABILITY KIT2014 IS BEING DEVELOPED AS AN INHALATION THERAPY FOR RESPIRATORY DISEASES INCLUDING CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), NON-CF BRONCHIECTASIS (NCFB) AND CYSTIC FIBROSIS (CF) KIT2014'S UNIQUE MODE OF ACTION IMPROVES RESPIRATORY SYMPTOMS BY PROMOTING BRONCHODILATION AND REDUCING LUNG INFLAMMATION TURIN, ITALY, JUNE 19, 2026 (GLOBE NEWSWIRE) -- KITHER BIOTECH PTY LTD AND KITHER BIOTECH SRL, A CLINICAL-STAGE BIOPHARMACEUTICAL GROUP OF COMPANIES DEVELOPING INNOVATIVE THERAPIES FOR RESPIRATORY DISEASES, TODAY ANNOUNCED THE SUCCESSFUL COMPLETION OF THEIR PHASE 1 CLINICAL STUDY OF KIT2014 IN HEALTHY PARTICIPANTS. WE ARE PLEASED TO REPORT THE SUCCESSFUL COMPLETION OF THIS FIRST-IN-HUMAN PHASE 1 STUDY WITH KIT2014, A SIGNIFICANT MILESTONE FOR KITHER BIOTECH, SAID DR. DIMITRIOS GOUNDIS, CEO OF KITHER BIOTECH.

KITHER BIOTECH SUCCESSFULLY COMPLETES PHASE 1 CLINICAL TRIAL OF KIT2014, A NOVEL INHALED PEPTIDE THERAPY FOR RESPIRATORY DISEASES

NORTHBROOK, ILL.--(BUSINESS WIRE)--CF INDUSTRIES HOLDINGS, INC. (NYSE: CF), A LEADING GLOBAL MANUFACTURER OF HYDROGEN AND NITROGEN PRODUCTS, TODAY ANNOUNCED RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2026. HIGHLIGHTS FIRST QUARTER 2026 NET EARNINGS(1) OF $615 MILLION, OR $3.98 PER DILUTED SHARE, EBITDA(2) OF $1.01 BILLION, AND ADJUSTED EBITDA(2) OF $983 MILLION. FIRST QUARTER 2026 FINANCIAL RESULTS REFLECT A GAIN OF APPROXIMATELY $170 MILLION FROM A LITIGATION SETTLEMENT TRAILING TWELVE MONT.

CF INDUSTRIES HOLDINGS, INC. REPORTS FIRST QUARTER 2026 NET EARNINGS OF $615 MILLION, ADJUSTED EBITDA OF $983 MILLION

NORTHBROOK, ILL.--(BUSINESS WIRE)--CF INDUSTRIES HOLDINGS, INC. (NYSE: CF) TODAY ANNOUNCED THAT ITS BOARD OF DIRECTORS HAS ELECTED ANDREW T. SCRIBNER AS EXECUTIVE VICE PRESIDENT AND CHIEF FINANCIAL OFFICER, EFFECTIVE MAY 26, 2026. MR. SCRIBNER WILL REPORT TO CHRISTOPHER D. BOHN, PRESIDENT AND CHIEF EXECUTIVE OFFICER, CF INDUSTRIES HOLDINGS, INC., AND SERVE AS A MEMBER OF THE COMPANY'S SENIOR LEADERSHIP TEAM. WE ARE PLEASED TO WELCOME ANDREW TO CF INDUSTRIES, SAID BOHN. HE IS A DISCIPLINED, F.

ANDREW T. SCRIBNER ELECTED EXECUTIVE VICE PRESIDENT AND CHIEF FINANCIAL OFFICER OF CF INDUSTRIES HOLDINGS, INC.

NORTHBROOK, ILL.--(BUSINESS WIRE)--CF INDUSTRIES HOLDINGS, INC. (NYSE: CF) TODAY REPORTED THAT ITS BOARD OF DIRECTORS HAS DECLARED A $0.50 PER SHARE DIVIDEND ON ITS COMMON STOCK. THE DIVIDEND WILL BE PAYABLE ON MAY 29, 2026, TO STOCKHOLDERS OF RECORD AS OF MAY 15, 2026. ABOUT CF INDUSTRIES HOLDINGS, INC. AT CF INDUSTRIES, OUR MISSION IS TO PROVIDE CLEAN ENERGY TO FEED AND FUEL THE WORLD SUSTAINABLY. WITH OUR EMPLOYEES FOCUSED ON SAFE AND RELIABLE OPERATIONS, ENVIRONMENTAL STEWARDSHIP, AND DISCI.

CF INDUSTRIES HOLDINGS, INC. DECLARES QUARTERLY DIVIDEND

NORTHBROOK, ILL.--(BUSINESS WIRE)--CF INDUSTRIES HOLDINGS, INC. (NYSE: CF) TODAY CONFIRMED THAT IT WILL REPORT ITS FIRST QUARTER 2026 RESULTS AFTER MARKET CLOSE ON WEDNESDAY, MAY 6, 2026. THE COMPANY PLANS TO HOST A CONFERENCE CALL TO DISCUSS THESE RESULTS AT 11:00 A.M. ET ON THURSDAY, MAY 7, 2026. INVESTORS CAN ACCESS THE CALL BY DIALING 833-634-5017 (TOLL-FREE) OR 412-902-4213 (INTERNATIONAL) AND ASK TO BE JOINED INTO THE CF INDUSTRIES CALL. THE CONFERENCE CALL ALSO WILL BE AVAILABLE LIVE ON.

CF INDUSTRIES HOLDINGS, INC. CONFIRMS DATES FOR FIRST QUARTER 2026 RESULTS AND CONFERENCE CALL, ANNOUNCES PARTICIPATION IN UPCOMING INVESTOR CONFERENCE

SAN DIEGO, MARCH 06, 2026 (GLOBE NEWSWIRE) -- SHAREHOLDER RIGHTS LAW FIRM JOHNSON FISTEL, PLLP IS INVESTIGATING CLAIMS ON BEHALF OF CF INDUSTRIES HOLDINGS, INC. (NYSE: CF) CONCERNING WHETHER THE OFFICERS AND DIRECTORS BREACHED THEIR FIDUCIARY DUTIES TO THE COMPANY AND ITS SHAREHOLDERS. WHAT SHOULD CF INDUSTRIES SHAREHOLDERS DO?

JOHNSON FISTEL INVESTIGATES CF INDUSTRIES HOLDINGS, INC. (CF) DIRECTORS FOR POTENTIAL BREACHES OF FIDUCIARY DUTY

NORTHBROOK, ILL.--(BUSINESS WIRE)--CF INDUSTRIES HOLDINGS, INC. (NYSE: CF), A LEADING GLOBAL MANUFACTURER OF HYDROGEN AND NITROGEN PRODUCTS, TODAY ANNOUNCED RESULTS FOR THE FULL YEAR AND FOURTH QUARTER ENDED DECEMBER 31, 2025. HIGHLIGHTS FULL YEAR 2025 NET EARNINGS(1) OF $1.46 BILLION, OR $8.97 PER DILUTED SHARE, EBITDA(2) OF $2.78 BILLION, AND ADJUSTED EBITDA(2) OF $2.89 BILLION FOURTH QUARTER 2025 NET EARNINGS OF $404 MILLION, OR $2.59 PER DILUTED SHARE, EBITDA OF $731 MILLION, AND ADJUSTED E.

CF Industries Holdings, Inc.

CF

Price

Financial Reports

No items found.

Press Releases

CF Industries Holdings, Inc.

CF.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financial Reports

No items found.

Press Releases

CF